文献速递主动脉疾病

使用术者改良倒转分支联合Zenith开窗支架移植物挽救既往血管腔内和开放修复失败

Use of physician-modified inverted limb in conjunction with Zenith fenestrated stent graft to rescue failed previous endovascular and open repair.
PubMed 文献 · J Vasc Surg · 2023-12-14

这项多中心回顾性研究评估了在最低肾动脉与主动脉或移植物分叉距离较短的患者中,将倒转分支与Zenith开窗支架移植物联合使用的结果;20例患者(38.5%)因长度限制需要该技术,技术成功率为100%,中位随访50个月无器械移位、组件分离、动脉瘤相关死亡及I型或III型内漏。

要点

  • 倒转分支联合Zenith开窗支架用于最低肾动脉至分叉距离短的患者,技术成功率为100%。
  • 中位随访50个月无器械移位、组件分离、动脉瘤相关死亡及I型或III型内漏。
  • 所有患者均观察到瘤囊回缩(95%)或稳定(5%),包括4例(25%)II型内漏患者。

核心结论

  • 作者认为,在最低肾动脉与主动脉或移植物分叉距离较短的患者中,使用倒转分支联合Zenith开窗支架治疗安全、有效,且长期结果优良。
  • 作者认为,该技术扩展了Zenith开窗支架的适应证,尤其是在既往血管腔内动脉瘤修复失败的患者中。

研究设计与样本

  • 本研究为多中心回顾性研究,基于前瞻性维护的数据库,纳入2013年至2023年间因复杂主动脉瘤、既往血管腔内动脉瘤修复失败或开放手术修复失败且最低肾动脉与主动脉或移植物分叉距离较短、接受Zenith开窗支架联合倒转分支治疗的患者。
  • 共52例患者接受失败的修复的血管腔内挽救,其中20例(38.5%)因最低肾动脉至主动脉或移植物分叉长度限制需要使用倒转分支进行再次衬里。
  • 20例患者中大多数(94%)为男性,平均年龄76.8±6.1岁;平均主动脉颈直径和动脉瘤大小分别为32±4 cm和7.2±1.3 cm。
  • 初次修复至失败的中位时间为36个月(四分位距[IQR],24-54个月);16例(80%)为美国麻醉医师协会III级,4例为IV级。
  • 共 targeting 78支血管并成功纳入;技术成功定义为植入器械无内漏、无转为主-单髂动脉或开放手术。

主要发现

  • 技术成功率为100%,中位估计失血量为100 mL(IQR,100-200 mL)。
  • 平均透视时间和剂量分别为61±18分钟和2754±1062 mGy。
  • 平均住院时间为2.75±2.15天;术后1例患者发生并发症,需行下肢筋膜切开术治疗骨筋膜室综合征。
  • 中位随访50个月(IQR,18-58个月)时,无器械移位、组件分离、动脉瘤相关死亡及I型或III型内漏。
  • 所有患者均观察到动脉瘤囊回缩(95%)或稳定(5%),包括4例(25%)II型内漏患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate outcomes and performance of inverted limbs (ILs) when used in conjunction with Zenith fenestrated stent grafts (Zfens) to treat patients with short distance between the lowest renal artery (RA) and aortic or graft bifurcation (A/GB). METHODS: This study was a multicenter, retrospective review of prospectively maintained database of patients with complex aortic aneurysms, failed endovascular aneurysm repair (EVAR), or open surgical repair (OSR) with short distance between LRA and A/GB treated using a combination of Zfen and an IL between 2013 and 2023. Endpoints included technical success, aneurysm sac regression, long-term device integrity, and target vessel patency. We defined technical success as implantation of the device with no endoleak, conversion to an aorto-uni-iliac or OSR. RESULTS: During this time, 52 patients underwent endovascular rescue of failed repair. Twenty (38.5%) of them required relining of the failed repairs using IL due to lowest RA to A/GB length restrictions. Two patients had undergone rescue with a fenestrated cuff alone but developed type III endoleaks. One patient with no previous implant had a short distance between the lowest RA and aortic bifurcation to accommodate the bifurcated distal device, and two patients had failed OSR or anastomotic pseudoaneurysms. The majority (94%) were men with a mean age of 76.8 ± 6.1 years. The mean aortic neck diameter and aneurysm size were 32 ± 4 cm and 7.2 ± 1.3 cm, respectively. The median time laps between initial repair and failure was 36 months (interquartile range [IQR], 24-54 months). Sixteen patients (80%) were classified as American Society of Anesthesiologists class III, whereas four were class IV. Seventy-eight vessels were targeted and successfully incorporated. Technical success was 100%, and median estimated blood loss was 100 mL (IQR, 100-200 mL). Mean fluoroscopy time and dose were 61 ± 18 minutes and 2754 ± 1062 mGy, respectively. Average hospital length of stay was 2.75 ± 2.15 days. Postoperative complication occurred in one patient who required lower extremity fasciotomy for compartment syndrome. At a median follow-up of 50 months (IQR, 18-58 months), there were no device migration, components separation, aneurysmal related mortality, and type I or type III endoleak. Aneurysm sac regression (95%) or stabilization (5%) was observed in all patients, including in four patients (25%) with type II endoleak. CONCLUSIONS: The use of IL in conjunction with Zfen to treat patients with short distance between the lowest RA and A/GB is safe, effective, and has excellent long-term results. The technique expands the indication of Zfen, especially in patients with failed previous EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Manunga J, Stanberry LI, Skeik N, et al. Use of physician-modified inverted limb in conjunction with Zenith fenestrated stent graft to rescue failed previous endovascular and open repair. J Vasc Surg. 2023. PMID: 38103807. doi:10.1016/j.jvs.2023.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。